This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Monitoring in Coeliac disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Monitoring in people with coeliac disease

  • referral should be considered for endoscopic intestinal biopsy for patients with coeliac disease if continued exposure to gluten has been excluded and:
    • serological titres are persistently high and show little or no change after 12months or
    • they have persistent symptoms, including diarrhoea, abdominal pain, weight loss, fatigue or unexplained anaemia

Offer an annual review to people with coeliac disease. During the review:

  • measure weight and height
  • review symptoms
  • consider the need for assessment of diet and adherence to the gluten-free diet
  • consider the need for specialist dietetic and nutritional advice

The GP or consultant should assess all of the following:

  • the need for a dual-energy X-ray absorptiometry (DEXA) scan or active treatment of bone disease Coeliac disease

  • the need for specific blood tests

  • the risk of long-term complications and comorbidities

  • the need for specialist referral

Reference:

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.